/PRNewswire/ Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological.
Scinai Immunotherapeutics (SCNI) Announces Promising Results in a Psoriatic Human Skin Model streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
JERUSALEM, Dec. 12, 2023 /PRNewswire/ Scinai Immunotherapeutics Ltd. , a biopharmaceutical company focused on development of inflammation and immunology biological products, is pleased to.
Data backs use of Scinai s aerosolized NanoAbs as a platform for the treatment of hyperinflammatory viral diseases, addressing significant medical needs
JERUSALEM, Dec. 11, 2023 /PRNewswire/.